SA 3004 · Productos farmacéuticos
Medicamentos dosificados
Datos actualizados el 18 de octubre de 2026 · datos de las listas 2026.10.2
En resumen
La UE no cobra arancel sobre los medicamentos dosificados del Mercosur, con o sin el acuerdo; el arancel de Brasil sobre los medicamentos dosificados de origen europeo, hoy de hasta el 12,7 %, llega a cero a más tardar en 2036 (2 de 146 líneas están excluidas).
Aranceles de un vistazo
En la UE, desde el Mercosur
11 líneas arancelariasArancel preferencial 2026
0 %
Exento en todas las líneas con desgravación en
Sin desgravación
Tasa base del acuerdo
0 %
Arancel NMF aplicado hoy
0 %
En Brasil, desde la UE
146 líneas arancelariasArancel preferencial 2026
0–12,7 %
Exento en todas las líneas con desgravación en
2036
Tasa base del acuerdo
0–14 %
Arancel NMF aplicado hoy
0–14 %
Calcule el arancel de su envío
Abre la calculadora con la partida 3004 y el sentido del comercio ya completados.
Sobre este producto
Los medicamentos envasados ya entran libres de arancel en la UE. El Mercosur desgrava sus aranceles sobre los medicamentos europeos en calendarios medios y largos, con dos líneas excluidas. El registro sanitario es un trámite aparte que el acuerdo no reemplaza.
Cómo baja el arancel, año a año
Arancel ad valorem más alto y más bajo de cada año entre las líneas que llegan a cero. Las líneas excluidas o solo con contingente mantienen su arancel y no se incluyen.
En la UE, desde el Mercosur
No hay nada que desgravar en este sentido: todas las líneas ya están exentas, excluidas o solo con contingente.
En Brasil, desde la UE
| Año | Arancel ad valorem | Líneas exentas |
|---|---|---|
| 2026 | 0–12,7 % | 35 / 146 |
| 2027 | 0–11,4 % | 35 / 146 |
| 2028 | 0–10,1 % | 35 / 146 |
| 2029 | 0–8,9 % | 35 / 146 |
| 2030 | 0–7,6 % | 35 / 146 |
| 2031 | 0–6,3 % | 35 / 146 |
| 2032 | 0–5 % | 35 / 146 |
| 2033 | 0–3,8 % | 35 / 146 |
| 2034 | 0–2,5 % | 62 / 146 |
| 2035 | 0–1,2 % | 62 / 146 |
| 2036 | 0 % | 144 / 146 |
Líneas por categoría de desgravación
La categoría fija el ritmo de la rebaja: 0 es exención desde la entrada en vigor, 4 a 15 son los años hasta cero, E es exclusión y las siglas indican contingentes o tratamientos especiales.
Mercosur → UE
- 0× 11
UE → Mercosur
- 10× 82
- 0× 33
- 8× 28
- E× 2
- 4× 1
Contingentes arancelarios
Ningún contingente arancelario se aplica a esta partida.
Aranceles en cada país del Mercosur
Cada miembro tiene su propia tasa base y su arancel NMF aplicado. La preferencia se calcula sobre la base o sobre el arancel aplicado cuando es menor (art. 2.4(7) del acuerdo), así que el arancel actual puede variar entre países.
| País | Tasa base | NMF aplicado | Preferencial 2026 | Cero en | Fuente del arancel aplicado |
|---|---|---|---|---|---|
| Brasil | 0–14 % | 0–14 %6 líneas no tienen una tasa única publicada | 0–12,7 % | 2036 | Brazil applied import duty, Res. Gecex 272/2021 Annexes II, V, VI, IX (MDIC), datos del 5 de octubre de 2026 |
| Argentina | 0–14 % | 0–14 %7 líneas no tienen una tasa única publicada | 0–12,7 % | 2036 | Argentina applied import duty (DIE), ARCA Arancel Integrado, datos del 18 de octubre de 2026 |
| Uruguay | 0–14 % | 0–12,6 %6 líneas no tienen una tasa única publicada | 0–12,7 % | 2036 | Uruguay applied import duty (Arancel Nacional, MEF), datos del 10 de febrero de 2025Copia manualMás de 180 días |
| Paraguay | 0–14 % | 0–12,6 %9 líneas no tienen una tasa única publicada | 0–12,7 % | 2036 | Paraguay applied import duty (Arancel Nacional Vigente, MEF), datos del 4 de noviembre de 2025Copia manualMás de 180 días |
Todas las líneas arancelarias
Las descripciones de las líneas son el texto en inglés de las listas (NC 2013 para la UE, NCM 2012 para el Mercosur).
En la UE, desde el Mercosur: 11 líneas
| Código | Descripción | Categoría | Base | NMF aplicado | 2026 | Final |
|---|---|---|---|---|---|---|
| 3004 10 00 | Medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale | 0 | Exento | Exento | Exento | Exento |
| 3004 20 00 | Medicaments containing antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic structure, or streptomycines or derivatives thereof) | 0 | Exento | Exento | Exento | Exento |
| 3004 31 00 | Medicaments containing insulin but not antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale | 0 | Exento | Exento | Exento | Exento |
| 3004 32 00 | Medicaments containing corticosteroid hormones, their derivatives or structural analogues but not antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale | 0 | Exento | Exento | Exento | Exento |
| 3004 39 00 | Medicaments containing hormones or steroids used as hormones but not antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing insulin or corticosteroid hormones, their derivatives or structural analogues) | 0 | Exento | Exento | Exento | Exento |
| 3004 40 20 | Medicaments containing ephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale | 0 | Exento | Exento | Exento | Exento |
| 3004 40 30 | Medicaments containing pseudoephedrine (INN) or its salts, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale | 0 | Exento | Exento | Exento | Exento |
| 3004 40 40 | Medicaments containing norephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale | 0 | Exento | Exento | Exento | Exento |
| 3004 40 80 | Medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. containing ephedrine, pseudoephedrine (inn), norephedrine or their salts) | 0 | Exento | Exento | Exento | Exento |
| 3004 50 00 | Medicaments containing provitamins, vitamins, incl. natural concentrates and derivatives thereof used primarily as vitamins, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale | 0 | Exento | Exento | Exento | Exento |
| 3004 90 00 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotic, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins or derivatives thereof used as vitamins) | 0 | Exento | Exento | Exento | Exento |
En Brasil, desde la UE: 146 líneas
| Código | Descripción | Categoría | Base | NMF aplicado | 2026 | Final |
|---|---|---|---|---|---|---|
| 3004 10 11 | Medicine containing ampicillin or its salts, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 10 12 | Medicine containing amoxicillin or its salts, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 10 13 | Medicine containing penicillin G benzathine, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 10 14 | Medicine containing penicillin G potassium, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 10 15 | Medicine containing penicillin G procaine, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 10 19 | Medicine containing other penicillin/its derivatives, in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 10 20 | Medicine containing streptomycins/its derivatives, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 11 | Medicine containing chloramphenicol, its palmitate, etc. in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 19 | Medicine containing amphenicols and other salts, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 21 | Medicine containing erythromycin or its salts, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 20 29 | Other medicine containing macrolides and its derivatives, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 31 | Medicine containing rifamycin SV sodium, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 32 | Medicine containing rifampicin, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 39 | Other medicine containing ansamycin and its deriv., in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 20 41 | Medicine containing lincomycin hydrochloride, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 20 49 | Other medicine containing lincosamides and its derivatives, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 51 | Medicine containing cephalothin sodium, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 20 52 | Medicine containing cephalothin/cephalexin monohydrate, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 20 59 | Other medicine containing cephalosporin, etc. in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 61 | Medicine containing gentamycin sulphate, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 20 62 | Medicine containing daunorubicin, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 20 63 | Medicine containing pirarubicin, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 20 69 | Other medicine containing aminoglycosides and its derivatives, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 71 | Medicine containing vancomycin, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 72 | Medicine containing actinomycins, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 20 73 | Medicine containing cyclosporin A, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 20 79 | Other medicine containing polypeptides and its derivatives, in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 20 91 | Medicine containing mitomycins, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 20 92 | Medicine containing tiamulin fumarate, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 20 93 | Medicine containing bleomycins or their salts, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 20 94 | Medicine containing imipenems, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 20 95 | Medicine with amphotericin b in liposome, doses, retail sale | 0 | Exento | Exento | Exento | Exento |
| 3004 20 99 | Medicine containing other antibiotics, in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 31 00 | Medicine containing insulin, in doses | E | 14 % | 12,6 % | 12,6 % | 12,6 % |
| 3004 32 10 | Medicine containing corticosteroid hormones, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 32 20 | Medicine containing spironolactone, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 32 90 | Medicine containing other derivatives of hormones analogues, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 39 11 | Medicine containing growth hormones (somatropin) in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 12 | Medicine containing hgc (chorionic gonadotrophin), in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 13 | Medicine containing menotrophins, in doses | 10 | 14 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 39 14 | Medicine containing acth (corticotrophin), in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 39 15 | Medicine containing pmsg (serum gonadotrophin), in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 39 16 | Medicine containing somatostatin or its salts, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 17 | Medicine containing buserelin or its acetate, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 18 | Medicine containing triptorelin or its salts, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 19 | Medicine containing leuprolide, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 21 | Medicine containing lh-rh (gonadorelin), in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 22 | Medicine containing oxytocin, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 23 | Medicine containing insulin salts, in doses | E | 14 % | 12,6 % | 12,6 % | 12,6 % |
| 3004 39 24 | Medicine containing timosins, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 25 | Medicine containing calcitonin, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 39 26 | Medicine containing octreotide, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 27 | Medicine containing goserelin or its acetate, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 28 | Medicine containing nafarelin or its acetate, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 29 | Medicine containing other polypeptides hormones, etc. in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 39 31 | Medicine containing oestradiol hemisuccinate, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 32 | Medicine containing oestradiol fenpropionate, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 33 | Medicine containing oestriol or its succinate, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 34 | Medicine containing allyloestrenol, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 35 | Medicine containing lynestrenol, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 36 | Medicine containing megestrol acetate, formestane, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 37 | Medicine containing desogestrel, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 39 | Medicine containing other estrogens and progestogens, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 39 81 | Medicine containing levothyroxine sodium, in doses | 10 | 12 % | 10,8 % | 9,8 % | Exentodesde 2036 |
| 3004 39 82 | Medicine containing liothyronine sodium, in doses | 10 | 12 % | 10,8 % | 9,8 % | Exentodesde 2036 |
| 3004 39 91 | Medicine containing sodium salt ac.9, 11, 15-trihyd, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 92 | Medicine containing tiratricol and its sodium salt, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 39 94 | Medicine containing spironolactone, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 39 99 | Other medicine containing hormones, in doses, etc | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 40 10 | Medicine containing vinblastine, vincristine, etc. in doses | 0 | Exento | – | Exento | Exento |
| 3004 40 20 | Medicine containing pilocarpine and its nitrate/hydrochloride, in doses | 10 | 14 % | – | 12,7 % | Exentodesde 2036 |
| 3004 40 30 | Medicine containing dihydroergocristine methanesulphonate, in doses | 8 | 8 % | – | 7,1 % | Exentodesde 2034 |
| 3004 40 40 | Medicine containing codeine or its salts, in doses | 10 | 14 % | – | 12,7 % | Exentodesde 2036 |
| 3004 40 50 | Medicine containing granisetron, tropisetron, etc. in doses | 0 | Exento | – | Exento | Exento |
| 3004 40 90 | Other medicine containing alkaloids, hormones, etc. in doses | 10 | 8 % | – | 7,2 % | Exentodesde 2036 |
| 3004 50 10 | Medicine containing calcium folinate (leucovorine), in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 50 20 | Medicine containing nicotinamide acid and its sodium salt, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 50 30 | Medicine containing hydroxycobalamine and its salts, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 50 40 | Medicine containing vitamina A1 (retinol), etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 50 50 | Medicine containing calcium d- pantothenate, etc. in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 50 60 | Medicine containing retinoic acid (tretinoin), in doses | 0 | Exento | 7,2 % | Exento | Exento |
| 3004 50 90 | Medicine containing other vitamins, provitamins, etc. in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 90 11 | Medicine containing streptokinase, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 12 | Medicine containing l-asparaginase, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 13 | Medicine containing deoxyribonuclease, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 19 | Medicine containing enzymes, in doses | 8 | 8 % | Exento | Exento | Exentodesde 2034 |
| 3004 90 21 | Medicine containing permethrin, propatyl nitrate, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 22 | Medicine containing deoxycholic acid, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 23 | Medicine containing gluconic acid, its salts and its esters, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 24 | Medicine containing o-acetylsalicylic acid, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 25 | Medicine containing calcium lactophosphate, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 26 | Medicine containing lactic acid, its salts, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 27 | Medicine containing nitroglycerine, in doses, for transdermal administration | 4 | 2 % | Exento | Exento | Exentodesde 2030 |
| 3004 90 28 | Medicine containing etretinate miltefosine, etc. in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 29 | Other medicine containing monocarboxylic acyclic, etc. in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 90 31 | Medicine containing tranylcypromine sulphate, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 32 | Medicine containing tranylcypromine sulphate, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 33 | Medicine containing clenbuterol or its hydrochloride, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 34 | Medicine containing tamoxifen or its citrate, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 35 | Medicine with levodopa/alfa-metildopa, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 36 | Medicine containing phenylephrine hydrochloride, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 37 | Medicine containing diclofenac sodium, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 38 | Medicine containing melfalan, chlorambucil, etc. in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 39 | Other medicine with compounds with amine functions, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 90 41 | Medicine containing metoclopramide, hydrochloride, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 42 | Medicine containing atenolol, prilocaine, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 43 | Medicine containing lidocaine and its hydrochloride, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 44 | Medicine containing fenproporex, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 45 | Medicine containing paracetamol or bromopride, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 46 | Medicine containing amitraz, cypermethrin, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 47 | Medicine containing chlorhexidine and its salts, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 48 | Medicine containing carmustine, lomustine, etc. in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 49 | Other medicine containing carboxyamide- function compounds, etc. in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 90 51 | Medicine containing isossorbide dinitrate, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 52 | Medicine containing thiapride, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 90 53 | Medicine containing etidronate disodium, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 54 | Medicine containing amiodarone hydrochloride, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 55 | Medicine containing nitrovin, moxidectin, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 57 | Medicine containing carbocisteine, sulfiram, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 58 | Medicine containing etoposide, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 59 | Other medicines containing products from position 29.30 to 29.32, etc. in doses | 10 | 8 % | 7,2 % | 6,5 % | Exentodesde 2036 |
| 3004 90 61 | Medicine containing terfenadine, talniflumate, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 62 | Medicine containing nifendipine, nitrendipine, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 63 | Medicine containing oxfendazole, albendazole, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 64 | Medicine containing triazolam, alprazolam, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 65 | Medicine containing phenytoin or its sodium salt, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 66 | Medicine containing 2-(2-methyl-3- chloroanilino) nicotinic, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 67 | Medicine containing nicarbazine, norfloxacin, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 68 | Medicine c/cyclosporine a, fluspirilene, etc. in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 69 | Other medicine containing heterocyclic compounds with nitrogenous heteroatoms, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 90 71 | Medicine containing levamisole and its salts, tetramisole, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 90 72 | Medicine containing sulfadiazine and its sodium salt, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 73 | Medicine containing ketazolam, sulpiride, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 74 | Medicine containing phthalylsulfathiazole, butanide, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 75 | Medicine containing fluphenazine enanthate, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 76 | Medicine containing furosemide, chlorthalidone, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 77 | Medicine containing tizanidine hydrochloride, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 78 | Medicine containing topotecan, uracil, tegafur, etc. in doses | 10 | 14 % | 14 % | 12,7 % | Exentodesde 2036 |
| 3004 90 79 | Medicine containing compounds of heterocyclic, etc. in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 90 91 | Medicine containing pollen extract, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 90 92 | Medicine containing disophenol, chyrsarobin, etc. in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 93 | Medicine containing diclofenac resinate, in doses | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 94 | Medicine containing silymarin, in doses | 8 | 8 % | 7,2 % | 6,4 % | Exentodesde 2034 |
| 3004 90 95 | Medicine containing propofol, busulfan, mitotane, in doses | 0 | Exento | Exento | Exento | Exento |
| 3004 90 96 | Iron dextran complex | 10 | 14 % | 12,6 % | 11,4 % | Exentodesde 2036 |
| 3004 90 99 | Other medicine containing products for therapeutic uses, etc. in doses | 10 | 14 % | 7,2 % | 6,5 % | Exentodesde 2036 |
Productos relacionados
Datos y método
Calculado con el motor de la calculadora a partir de las listas del acuerdo (Anexo 2-A) y los archivos de aranceles aplicados, para el año 2026 del acuerdo. Las cifras Mercosur → UE suponen origen brasileño, que solo importa en los pocos contingentes por país; las cifras UE → Mercosur son de Brasil, salvo que la tabla por país diga otra cosa.
- EU TARIC via Swedish Customs Tariff File Distribution (TF), 16 de octubre de 2026
- Brazil applied import duty, Res. Gecex 272/2021 Annexes II, V, VI, IX (MDIC), 5 de octubre de 2026
- Argentina applied import duty (DIE), ARCA Arancel Integrado, 18 de octubre de 2026
- Uruguay applied import duty (Arancel Nacional, MEF), 10 de febrero de 2025 · Copia manual · Más de 180 días
- Paraguay applied import duty (Arancel Nacional Vigente, MEF), 4 de noviembre de 2025 · Copia manual · Más de 180 días
Metodología y fuentes de datos
Son estimaciones, no asesoramiento jurídico ni aduanero. Consulte las listas oficiales antes de usar un arancel.